{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:25:07Z","timestamp":1784129107543,"version":"3.55.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.amjcard.2013.05.037","type":"journal-article","created":{"date-parts":[[2013,6,29]],"date-time":"2013-06-29T11:16:02Z","timestamp":1372504562000},"page":"1013-1018","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["QTc Interval Screening in an Opioid Treatment Program"],"prefix":"10.1016","volume":"112","author":[{"given":"David F.","family":"Katz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaishali","family":"Khatri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Becki","family":"Bucher-Bartelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Traut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Lundin-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip S.","family":"Mehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mori J.","family":"Krantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2013.05.037_bib1","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1056\/NEJM200011023431802","article-title":"A\u00a0comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence","volume":"343","author":"Johnson","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2013.05.037_bib2","first-page":"493","article-title":"Vital signs: risk for overdose from methadone used for pain relief\u2014United States 1999\u20132010","volume":"61","author":"Paulozzi","year":"2012","journal-title":"Morbid Mortal Wkly Rep"},{"key":"10.1016\/j.amjcard.2013.05.037_bib3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/J354v19n04_05","article-title":"Pharmacokinetics of methadone","volume":"19","author":"Lugo","year":"2005","journal-title":"J\u00a0Pain Palliat Care Pharmacother"},{"key":"10.1016\/j.amjcard.2013.05.037_bib4","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1124\/jpet.102.038240","article-title":"Influence of opioid agonists on cardiac human ether-a-go-go-related gene K(+) currents","volume":"303","author":"Katchman","year":"2002","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.amjcard.2013.05.037_bib5","doi-asserted-by":"crossref","first-page":"501","DOI":"10.7326\/0003-4819-137-6-200209170-00010","article-title":"Torsade de pointes associated with very-high-dose methadone","volume":"137","author":"Krantz","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjcard.2013.05.037_bib6","doi-asserted-by":"crossref","first-page":"735","DOI":"10.7326\/0003-4819-158-10-201305210-00008","article-title":"Trends in reporting of methadone-associated cardiac arrhythmia events, 1997--2011","volume":"158","author":"Kao","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjcard.2013.05.037_bib7","doi-asserted-by":"crossref","first-page":"387","DOI":"10.7326\/0003-4819-150-6-200903170-00103","article-title":"QTc interval screening in methadone treatment","volume":"150","author":"Krantz","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjcard.2013.05.037_bib8","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/10550887.2011.610707","article-title":"CSAT's QT interval screening in methadone report: outrageous fortune or sea of troubles?","volume":"30","author":"Bart","year":"2011","journal-title":"J\u00a0Addict Dis"},{"key":"10.1016\/j.amjcard.2013.05.037_bib9","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jpainsymman.2007.11.003","article-title":"Methadone: to ECG or not to ECG\u2026that is still the question","volume":"36","author":"Cruciani","year":"2008","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.amjcard.2013.05.037_bib10","doi-asserted-by":"crossref","first-page":"417","DOI":"10.7326\/0003-4819-150-6-200903170-00111","article-title":"First do no harm\u2026reduction?","volume":"150","author":"Gourevitch","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjcard.2013.05.037_bib11","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/10550887.2011.610704","article-title":"First, do no harm: QT interval screening in methadone maintenance treatment","volume":"30","author":"Haigney","year":"2011","journal-title":"J\u00a0Addict Dis"},{"key":"10.1016\/j.amjcard.2013.05.037_bib12","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/10550887.2011.610708","article-title":"QT or not QT, that is the question: routine electrocardiograms for individuals in methadone maintenance treatment","volume":"30","author":"Stimmel","year":"2011","journal-title":"J\u00a0Addict Dis"},{"key":"10.1016\/j.amjcard.2013.05.037_bib13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/10550887.2011.610710","article-title":"QT interval screening in methadone maintenance treatment: report of a SAMHSA expert panel","volume":"30","author":"Martin","year":"2011","journal-title":"J\u00a0Addict Dis"},{"key":"10.1016\/j.amjcard.2013.05.037_bib14","unstructured":"American Association for the Treatment of Opioid Dependence. QTc Interval Screening\u2014AATOD Policy and Guidance Statement. Available at: http:\/\/www.aatod.org\/qtc.html. Accessed May 10, 2012."},{"key":"10.1016\/j.amjcard.2013.05.037_bib15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research Electronic Data Capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J\u00a0Biomed Inform"},{"key":"10.1016\/j.amjcard.2013.05.037_bib16","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1360-0443.2006.01668.x","article-title":"Corrected-QT intervals as related to methadone dose and serum level in methadone maintenance treatment (MMT) patients: a cross-sectional study","volume":"102","author":"Peles","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.amjcard.2013.05.037_bib17","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1001\/archinte.167.22.2469","article-title":"QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial","volume":"167","author":"Wedam","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjcard.2013.05.037_bib18","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.amjcard.2004.11.055","article-title":"Impact of methadone treatment on cardiac repolarization and conduction in opioid users","volume":"95","author":"Martell","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2013.05.037_bib19","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/S0002-9149(02)02337-8","article-title":"Torsades de pointes associated with nonantiarrhythmic drugs and observations on gender and QTc","volume":"89","author":"Bednar","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2013.05.037_bib20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/10550880903436044","article-title":"Onsite QTc interval screening for patients in methadone maintenance treatment","volume":"29","author":"Fareed","year":"2010","journal-title":"J\u00a0Addict Dis"},{"key":"10.1016\/j.amjcard.2013.05.037_bib21","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1465-3362.2010.00237.x","article-title":"Methadone maintenance, QTc and Torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?","volume":"30","author":"Mayet","year":"2011","journal-title":"Drug Alcohol Rev"},{"key":"10.1016\/j.amjcard.2013.05.037_bib22","first-page":"566","article-title":"QT prolongation and arrhythmia risk in methadone maintenance treatment","volume":"2","author":"Barbhaiya","year":"2011","journal-title":"J\u00a0Innov Card Rhythm Managet"},{"key":"10.1016\/j.amjcard.2013.05.037_bib23","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1592\/phco.23.6.802.32186","article-title":"Dose-related effects of methadone on QT prolongation in a series of patients with Torsade de pointes","volume":"23","author":"Krantz","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.amjcard.2013.05.037_bib24","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/01.md.0000085057.63483.9b","article-title":"Torsade de pointes due to noncardiac drugs: most patients have easily identifiable risk factors","volume":"82","author":"Zeltser","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.amjcard.2013.05.037_bib25","series-title":"Guidance for Industry: E14 Clinical Evaluation of QT\/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs","author":"US Food and Drug Administration, Center for Drug Evaluation and Research","year":"2005"},{"key":"10.1016\/j.amjcard.2013.05.037_bib26","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/clpt.2011.273","article-title":"A\u00a0modeling and simulation approach to characterize methadone QT prolongation using pooled data from five clinical trials in MMT patients","volume":"91","author":"Florian","year":"2012","journal-title":"Clin Pharmacol Ther"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914913012356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914913012356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:25:51Z","timestamp":1757571951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914913012356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0002914913012356"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2013.05.037","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"QTc Interval Screening in an Opioid Treatment Program","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2013.05.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}